Investor · 2 deals
Every published round Qatar Investment Authority (QIA) took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| AdvanCell | Series D+ | 15 Jul 2026 | $450m | Participant | Forbes Australia (3 Sep 2026), Forbes Australia (16 Jul 2026), Brandon Capital, advancell.com.au, Brandon Capital portfolio, Brandon Capital portfolio, Tenmile portfolio | |
| Synchron | Series D+ | Nov 2025 | $305m | Participant | Startup Daily (3 Feb 2026), Startup Daily (23 Dec 2025), SmartCompany (23 Dec 2025), Startup Daily (9 Nov 2025), Startup Daily (7 Nov 2025), SmartCompany (7 Nov 2025) |
Companies Qatar Investment Authority (QIA) has backed in a published round, and companies whose existing shares it bought off another holder.
Fund closes reported for Qatar Investment Authority (QIA), as distinct from the investments it has made.
Companies Qatar Investment Authority (QIA) has backed that another company then bought. An exit for the holding, not a deal Qatar Investment Authority (QIA) did.
Stories naming Qatar Investment Authority (QIA). Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Brisbane radiopharmaceutical developer AdvanCell has closed an oversubscribed Series D round, led by Ally Bridge Group and Alpha Wave with several institutional investors returning, to fund late-stage prostate cancer trials and US manufacturing.